Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia
NCT04549597
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
333
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease Requiring Chronic Dialysis
Hyperphosphatemia
Interventions
DRUG:
Tenapanor
Sponsor
Ardelyx